Alvotech Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for ALVO, updated each market day.
ALVO AI Sentiment
AI predicts Alvotech Ordinary Shares stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Alvotech Ordinary Shares
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Exchange
Market Cap
$1,905,402,982
Cap Tier
Employees
1,460
Listed Since
June 16, 2022
Website
ALVO Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ALVO Volatility
Alvotech Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
